Casdin Private Growth Equity Fund, L.P.
Director · STANDARD BIOTOOLS INC.
Every open-market stock purchase Casdin Private Growth Equity Fund, L.P. has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where those buys landed inside insider clusters and how the prices paid compare to where the stock trades now.
Where the buys stand today
- LABSTANDARD BIOTOOLS INC.
3 purchases totalling $2.3M at an average of $1.72 per share. See all insider buying in LAB →
Avg price paid$1.72Latest price—Market capUnknown
Cluster participation
Qualifying buys grouped with other insiders buying the same stock — the pattern this site exists to catch.
All reported buys
Follow new qualifying clusters involving Casdin Private Growth Equity Fund, L.P. or other insiders
Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.
About this data
Figures are parsed from Casdin Private Growth Equity Fund, L.P.'s Form 4 filings on SEC EDGAR (CIK 1823061) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.
This page is informational and reflects public filing data. It is not investment advice.